These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: chemotherapy in patients with neuroendocrine tumors. Eriksson B; Annibale B; Bajetta E; Mitry E; Pavel M; Platania M; Salazar R; Plöckinger U; ; Neuroendocrinology; 2009; 90(2):214-9. PubMed ID: 19713713 [No Abstract] [Full Text] [Related]
8. Role of chemotherapy in malignant thymoma. Valente M; Schinzari G; Ricciotti A; Barone C Ann Ital Chir; 2007; 78(5):377-80. PubMed ID: 18338542 [TBL] [Abstract][Full Text] [Related]
12. The chemotherapy of malignant disease. Bottomley RH J Okla State Med Assoc; 1966 Jun; 59(6):287-96. PubMed ID: 5947443 [No Abstract] [Full Text] [Related]
13. [Chemotherapy of malignant trophoblastic growths]. LEVITAN R Harefuah; 1959 Jan; 56(1):3-5. PubMed ID: 13630447 [No Abstract] [Full Text] [Related]
14. [Progress in the chemotherapy of malignant diseases]. PATERSON E Sem Med; 1958 Sep; 112(Supp 17):451-2 passim. PubMed ID: 13602888 [No Abstract] [Full Text] [Related]
15. [Chemotherapy of malignant neoplasms. VIII. The remaining cytostatics]. Beran M; Semonský M; Semonská S Cesk Farm; 1980 May; 29(3-4):106-5. PubMed ID: 7407946 [No Abstract] [Full Text] [Related]
16. [Intrathecal infusion of the antineoplastic agents for meningeal dissemination]. Hodozuka A; Hayashi Y; Annei R; Hiroshima S; Saito M; Orimoto R; Sato M; Tanaka T Gan To Kagaku Ryoho; 2008 Jun; 35(6):900-5. PubMed ID: 18633217 [TBL] [Abstract][Full Text] [Related]
17. [Therapy of malignant tumors with cytostatic substances]. RITTER L; BEDACHT R Arztl Forsch; 1958 May; 12(5):I/266-72. PubMed ID: 13533086 [No Abstract] [Full Text] [Related]